Future Tense in Contractual Language Found Insufficient to Convey Title, Depriving Party of Right to License Patent

Mar 29, 2022

Reading Time : 2 min

Plaintiff Lambeth Magnetic Structures, LLC (LMS) filed a patent infringement lawsuit against Defendants Seagate Technology (US) Holdings, Inc. and Seagate Technology LLC (collectively, “Seagate”). Seagate filed affirmative defenses, including lack of standing and express license. LMS subsequently moved for summary judgment with respect to those defenses on the basis that U.S. Patent No. 7,128,988 (the “ʼ988 Patent”) was assigned to LMS and not Carnegie Mellon University (CMU). LMS argued that it had standing to sue as the owner of the ‘988 Patent and that CMU could not have granted a license to Seagate because it never owned the ‘988 Patent. The court disagreed and denied LMS’s motion for summary judgment. The court found that the terms in an intellectual property policy and sponsorship agreement—which provided that intellectual property “shall be owned” or “shall become the property of” the university—constituted a present assignment of the ‘988 Patent to CMU.

Subsequently, the Federal Circuit in Omni MedSci v. Apple Inc. issued a decision regarding whether an assignee of patents had standing to sue in view of an intellectual property policy containing similar terms. 7 F.4th 1148 (Fed. Cir. 2021). The Federal Circuit in Omni MedSci concluded that the language “shall be the property of” did not amount to a present assignment because the “absence of an active verbal expression of present execution is a substantive indication that a present automatic assignment [is] not intended.” Id. at 1156. And, therefore, the Federal Circuit affirmed the district court’s denial of Apple’s motion to dismiss for lack of standing.

Because such contractual language in Omni MedSci did not create an automatic present assignment, LMS filed a motion for reconsideration of the district court’s initial summary judgment ruling. In light of this controlling Federal Circuit precedent, the district court granted that motion and held that LMS was entitled to summary judgment on Seagate’s affirmative defenses. According to the court, like in Omni MedSci, the contractual language with CMU lacked an active verbal expression of present execution, and hence did not result in an automatic assignment; therefore, the court concluded that CMU could not have licensed the ‘988 Patent to Seagate.

Practice Tip: Some parties routinely rely on intellectual property agreements and policies when developing new products and technologies. If those parties are seeking to automatically assign ownership of inventions, they should avoid agreements using passive verbs in indefinite or future tenses, such as “shall be the property of.” Rather, they should use present tense words of execution to indicate a present assignment and a clear grant of intellectual property rights.

Lambeth Magnetic Structures, LLC v. Seagate Technology (US) Holdings, Inc. et al, Case No. 2-16-cv-00538 (WDPA Mar. 14, 2022)

Share This Insight

Previous Entries

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

IP Newsflash

September 17, 2025

A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.

...

Read More

IP Newsflash

September 9, 2025

The Federal Circuit has affirmed the PTAB’s determination that a patent challenger did not show the challenged claims were unpatentable for obviousness. The Federal Circuit concluded that substantial evidence, which included expert testimony, showed there was no motivation to combine the references.

...

Read More

IP Newsflash

August 29, 2025

In a recent order addressing four IPR proceedings, the PTAB exercised its inherent authority under 37 C.F.R. § 42.5(a) to sua sponte authorize post-hearing discovery on a potentially dispositive privity issue. The order followed a Director review decision that vacated and remanded earlier IPRs involving the same parties, patent family, and privity issue. 

...

Read More

IP Newsflash

August 29, 2025

The Patent Trial and Appeal Board denied institution of an inter partes review petition in part because it determined that a patent reference was not prior art under the common ownership exception of pre-AIA 35 U.S.C. § 103(c)(1).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.